butylhydroxybutylnitrosamine has been researched along with Precancerous Conditions in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (51.02) | 18.7374 |
| 1990's | 12 (24.49) | 18.2507 |
| 2000's | 8 (16.33) | 29.6817 |
| 2010's | 4 (8.16) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arantes-Rodrigues, R; Colaço, A; Ferreira, R; Gaivão, I; Neuparth, MJ; Oliveira, P; Palmeira, C; Pinto-Leite, R; Pires, MJ; Santos, L | 1 |
| Doi, K; Fang, H; Fujioka, M; Gi, M; Kakehashi, A; Tachibana, H; Wanibuchi, H; Xie, XL; Yamano, S | 1 |
| Dahm, HH; Rübben, H; von der Haar, C | 1 |
| Dahm, HH; Lehnen-Holtum, V; Rübben, H | 1 |
| Boring, D; Grubbs, CJ; Juliana, MM; Kopelovich, L; Lubet, RA; Patlolla, J; Rao, CV; Steele, VE; Zhang, Y | 1 |
| Doi, K; Fukushima, S; Mitsuhashi, M; Morimura, K; Nakatani, T; Wada, S; Wanibuchi, H; Wei, M | 1 |
| Asano, N; Hata, K; Hirose, Y; Iwasaki, T; Kobayashi, H; Kuno, T; Mori, H; Oyama, T; Qiang, SH; Yamada, Y; Zhi, H | 1 |
| Lopes, CA; Lourenço, LM; Oliveira, PA; Palmeira, C | 1 |
| Hwang, CH; Kim, HJ; Park, JY; Sohng, I | 1 |
| Colaço, A; De la Cruz, LF; Lopes, C; Lopes, P; Oliveira, PA | 1 |
| Endho, N; Hashimoto, Y; Hojo, H; Masuko, T | 1 |
| Fukushima, S; Ito, N; Koiso, K; Niijima, T; Ohtani, M | 1 |
| Fukushima, S; Ito, N; Koiso, K; Niijima, T; Ohtani, M; Okamura, T; Sakata, T | 1 |
| Fukushima, S; Imaida, K; Ito, N; Miyata, Y | 1 |
| Fukushima, S; Ito, N; Nakanishi, K; Shirai, T | 1 |
| Hashimoto, Y; Masuko, T | 1 |
| Fukushima, S; Hasegawa, R; Hirose, M; Ito, N; Murasaki, G; Nakanishi, K | 1 |
| Fukushima, S; Hatano, A; Hirose, M; Ito, N; Nakanowatari, J; Okuda, M | 1 |
| Arai, M; Fukushima, S; Ito, N; Shirai, T; Tsuda, H | 1 |
| Kakizoe, T; Kawachi, T; Komatsu, H; Niijima, T; Sugimura, T | 1 |
| Arai, M; Babaya, K; Fukushima, S; Ito, N; Miyata, Y; Murasaki, G | 1 |
| Hirose, M; Imaida, K; Shibata, M; Shirai, T; Tagawa, Y; Takahashi, S | 1 |
| Kojima, T; Mori, H; Morishita, Y; Okumura, A; Suzui, M; Tanaka, T | 1 |
| Fan, X | 1 |
| Fukushima, S; Kishimoto, T; Lee, CC; Sugimura, K; Wada, S; Wanibuchi, H; Yamamoto, S | 1 |
| Deguchi, T; Hirose, Y; Kawada, Y; Mori, H; Tanaka, T; Yang, M | 1 |
| Ariel, I; Ayesh, S; de Groot, N; Elkin, M; Hochberg, A; Schneider, T | 1 |
| Endo, G; Fukushima, S; Li, W; Salim, EI; Wanibuchi, H; Yamamoto, S; Yoshida, K | 1 |
| Grubbs, CJ; Hill, DL; Kelloff, GJ; Koki, AT; Leahy, KM; Lubet, RA; Masferrer, JL; Seibert, K; Steele, VE | 1 |
| Deguchi, T; Hara, A; Katayama, M; Mori, H; Sugie, S; Tanaka, T; Vinh, PQ; Yamada, Y | 1 |
| Kunze, E; Schatt, S; Schauer, A | 1 |
| Knuze, E; Schauer, A | 1 |
| Becci, PJ; Grubbs, CJ; Moon, RC; Thompson, HJ | 1 |
| Kakizoe, T; Kawachi, T; Okada, M | 1 |
| Fukushima, S; Kinoshita, H; Miyata, Y; Murasaki, G; Tsuda, H | 1 |
| Ito, N | 1 |
| Institoris, L; Jeney, A; Szende, B | 1 |
| Asamoto, M; de Camargo, JL; Fukushima, S; Kato, T; Shirai, T | 1 |
| Bach, PH | 1 |
| Kawada, Y; Kobayashi, S; Kuriyama, M; Mori, H; Ohno, T; Takeuchi, T; Tanaka, T; Yamamoto, N | 1 |
| Fukushima, S | 2 |
| Fukushima, S; Inoue, K; Kakizoe, T; Ohtaguro, K; Ohtani, M; Okamura, T | 1 |
| Akagi, A; Otsuka, H | 1 |
| Kawano, S; Mimata, H; Ogata, J; Shimada, T; Takeshita, M | 1 |
| Kimura, S; Kinoshita, Y; Maekawa, M; Nishio, S; Ozaki, Y; Wada, S | 1 |
| Hiasa, Y; Kitahori, Y; Konishi, N; Shimoyama, T | 1 |
| Fukushima, S; Inoue, K; Ito, N; Kurata, Y; Tamano, S | 1 |
| Fukushima, S; Hirose, M; Ito, N; Masui, T; Miyata, Y | 1 |
2 review(s) available for butylhydroxybutylnitrosamine and Precancerous Conditions
| Article | Year |
|---|---|
A molecular basis for target-cell toxicity and upper urothelial carcinoma in analgesic abusers and patients with Balkan endemic nephropathy.
Topics: Analgesics; Animals; Balkan Nephropathy; Butylhydroxybutylnitrosamine; Carcinogenicity Tests; Carcinogens; Cocarcinogenesis; Disease Models, Animal; Epithelium; Europe; FANFT; Humans; Hyperplasia; Incidence; Kidney Neoplasms; Kidney Papillary Necrosis; Models, Biological; Mycotoxicosis; Ochratoxins; Precancerous Conditions; Rats; Rats, Inbred Strains; Rodentia; Smoking; Substance-Related Disorders; Ureteral Neoplasms | 1991 |
Modification of tumor development in the urinary bladder.
Topics: Animals; Antineoplastic Agents; Antioxidants; Butylhydroxybutylnitrosamine; Cocarcinogenesis; FANFT; Methylnitrosourea; Precancerous Conditions; Urinary Bladder Neoplasms | 1991 |
47 other study(ies) available for butylhydroxybutylnitrosamine and Precancerous Conditions
| Article | Year |
|---|---|
Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer.
Topics: Animals; Antineoplastic Agents; Butylhydroxybutylnitrosamine; Cell Cycle Checkpoints; Cell Proliferation; Comet Assay; Cyclooxygenase Inhibitors; DNA Damage; Flow Cytometry; Humans; Injections, Intraperitoneal; Male; Meloxicam; Mice; Mice, Inbred ICR; Microscopy; Neoplasms, Experimental; Precancerous Conditions; Thiazines; Thiazoles; Urinary Bladder Neoplasms | 2013 |
Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats.
Topics: Animals; Apoptosis; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma; Cell Proliferation; Cocarcinogenesis; Dietary Supplements; Dose-Response Relationship, Drug; Ethanol; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Male; Plant Extracts; Precancerous Conditions; Propolis; Random Allocation; Rats, Inbred F344; Rats, Mutant Strains; Solvents; Urinary Bladder; Urinary Bladder Neoplasms | 2015 |
DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; DNA; Female; Precancerous Conditions; Rats; Rats, Wistar; Urinary Bladder Neoplasms | 2016 |
[Karyometry of BBN-induced precancerosis of the urothelium : An experimental analysis].
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Disease Models, Animal; Karyometry; Precancerous Conditions; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Urinary Bladder Neoplasms; Urothelium | 2016 |
Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers.
Topics: Alkylating Agents; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; Butylhydroxybutylnitrosamine; Carcinogens; Colonic Neoplasms; Diet; Female; Male; Mammary Neoplasms, Experimental; Methylnitrosourea; Naproxen; Nitric Oxide Donors; Precancerous Conditions; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Urinary Bladder Neoplasms | 2009 |
Significance of overexpression of metallothionein in mouse urinary bladder focal lesions induced by treatment with N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Topics: Animals; Apoptosis; Butylhydroxybutylnitrosamine; Carcinogens; Immunohistochemistry; Male; Metallothionein; Mice; Mice, Inbred C57BL; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Urinary Bladder; Urinary Bladder Neoplasms | 2003 |
Chemoprevention of mouse urinary bladder carcinogenesis by fermented brown rice and rice bran.
Topics: Analysis of Variance; Animals; Butylhydroxybutylnitrosamine; Cell Proliferation; Diet; Hyperplasia; Male; Mice; Mice, Inbred ICR; Nucleolus Organizer Region; Oryza; Precancerous Conditions; Silver Staining; Urinary Bladder; Urinary Bladder Neoplasms | 2006 |
Evaluation of DNA content in preneoplastic changes of mouse urinary bladder induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; DNA; Female; Image Processing, Computer-Assisted; Mice; Precancerous Conditions; Urinary Bladder Neoplasms | 2005 |
Cytokeratin-20 and seminal vesicle secretory protein VI as possible marker proteins in urinary bladder preneoplastic lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Topics: Animals; Biomarkers; Butylhydroxybutylnitrosamine; Keratin-20; Keratins; Male; Precancerous Conditions; Proteomics; Rats; Rats, Sprague-Dawley; Seminal Vesicle Secretory Proteins; Urinary Bladder Neoplasms | 2006 |
E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
Topics: Animals; Butylhydroxybutylnitrosamine; Cadherins; Carcinoma, Papillary; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Female; Hyperplasia; Neoplasm Invasiveness; Papilloma; Precancerous Conditions; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms; Urothelium | 2006 |
Mixed lymphocyte-autologous tumor cell reaction with primary rat bladder tumors: difficulty in the discrimination of tumor-specific antigen.
Topics: Animals; Antigens, Neoplasm; Butylhydroxybutylnitrosamine; Epitopes; Lymphocyte Culture Test, Mixed; Male; Neoplasms, Experimental; Papilloma; Precancerous Conditions; Rats; Rats, Inbred ACI; Urinary Bladder Neoplasms | 1982 |
Effects of intravesical instillation of antitumor drugs on the induction of preneoplastic bladder lesions in rats.
Topics: Animals; Butylhydroxybutylnitrosamine; Doxorubicin; Female; Hyperplasia; Mitomycin; Mitomycins; Precancerous Conditions; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1983 |
Effects of intravesical instillation of antitumor chemotherapeutic agents on bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Antineoplastic Agents; Butylhydroxybutylnitrosamine; Doxorubicin; Drug Synergism; Female; Hyperplasia; Mitomycin; Mitomycins; Nitrosamines; Papilloma; Precancerous Conditions; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1984 |
Promoting effects of unilateral ureteric ligation on two-stage urinary bladder carcinogenesis in rats.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Hyperplasia; Kidney; Ligation; Liver; Male; Precancerous Conditions; Rats; Rats, Inbred F344; Ureter; Urinary Bladder Neoplasms | 1984 |
Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
Topics: 2-Acetylaminofluorene; Animals; Butylhydroxybutylnitrosamine; Carcinogens; Dose-Response Relationship, Drug; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Membrane Potentials; Neoplasms, Experimental; Nitrosamines; Phenobarbital; Precancerous Conditions; Rats; Saccharin; Urinary Bladder Neoplasms | 1983 |
Emergence of an epidermis-associated cell surface antigen in epithelial cells of the rat urinary bladder in carcinogenesis.
Topics: Animals; Antigens, Surface; Butylhydroxybutylnitrosamine; Cell Membrane; Cells, Cultured; Epidermis; Epithelium; Hemadsorption; Male; Neoplasms, Experimental; Precancerous Conditions; Rats; Rats, Inbred Strains; Urinary Bladder; Urinary Bladder Neoplasms | 1981 |
Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma; Epithelium; Hyperplasia; Kinetics; Male; Nitrosamines; Papilloma; Precancerous Conditions; Rats; Rats, Inbred Strains; Urinary Bladder Neoplasms | 1982 |
Effect of partial cystectomy on the induction of pre-neoplastic lesions in rat bladder initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by bladder carcinogens and promoters.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cyclamates; FANFT; Male; Neoplasms, Experimental; Nitrosamines; Precancerous Conditions; Rats; Rats, Inbred F344; Saccharin; Tryptophan; Urinary Bladder; Urinary Bladder Neoplasms | 1982 |
Induction of preneoplastic and neoplastic lesions in rats treated N-nitroso compounds.
Topics: Animals; Butylhydroxybutylnitrosamine; Diethylnitrosamine; Dimethylnitrosamine; Dose-Response Relationship, Drug; Liver Neoplasms; Male; Neoplasms, Experimental; Nitrosamines; Precancerous Conditions; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1982 |
Maintenance by saccharin of membrane alterations of rat bladder cells induced by subcarcinogenic treatment with bladder carcinogens.
Topics: Animals; Butylhydroxybutylnitrosamine; Cell Aggregation; Cell Membrane; Cocarcinogenesis; Concanavalin A; Diet; FANFT; Male; Neoplasms, Experimental; Precancerous Conditions; Rats; Rats, Inbred Strains; Saccharin; Urinary Bladder; Urinary Bladder Neoplasms | 1981 |
Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Butylhydroxybutylnitrosamine; Cricetinae; Etretinate; Hyperplasia; Male; Mice; Nitrosamines; Papilloma; Precancerous Conditions; Rats; Tretinoin; Urinary Bladder; Urinary Bladder Neoplasms | 1980 |
Differences in cell proliferation and apoptosis between reversible and irreversible mucosal lesions associated with uracil-induced urolithiasis in N-butyl-N-(4-hydroxybutyl)nitrosamine-pretreated.
Topics: Animals; Apoptosis; Butylhydroxybutylnitrosamine; Carcinogens; Cell Division; Male; Microscopy, Electron; Mucous Membrane; Papilloma; Precancerous Conditions; Rats; Rats, Inbred F344; Uracil; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Calculi | 1995 |
Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin.
Topics: Animals; Anticarcinogenic Agents; beta Carotene; Body Weight; Butylhydroxybutylnitrosamine; Canthaxanthin; Carotenoids; Liver; Male; Mice; Mice, Inbred ICR; Nucleolus Organizer Region; Organ Size; Precancerous Conditions; Silver Staining; Urinary Bladder Neoplasms; Xanthophylls | 1994 |
[Inhibitory effect of antitumor-B and retinamide on precancerous lesions of the bladder in rats].
Topics: Animals; Antineoplastic Agents, Phytogenic; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Drugs, Chinese Herbal; Precancerous Conditions; Rats; Rats, Wistar; Tretinoin; Urinary Bladder Neoplasms | 1993 |
Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Topics: Animals; Ascorbic Acid; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Cell Nucleus; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Hyperplasia; Male; Neoplasm Proteins; Papilloma; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats; Rats, Inbred F344; RNA, Messenger; Tumor Suppressor Protein p53; Urinary Bladder; Urinary Bladder Neoplasms | 1997 |
Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice.
Topics: Administration, Oral; Animals; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Carcinogens; Diosmin; DNA, Neoplasm; Drug Combinations; Hesperidin; Male; Mice; Mice, Inbred ICR; Nucleolus Organizer Region; Precancerous Conditions; Silver Staining; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1997 |
The dynamics of the imprinted H19 gene expression in the mouse model of bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cell Transformation, Neoplastic; Disease Models, Animal; Disease Progression; Epithelial Cells; Female; Gene Expression; Genomic Imprinting; In Situ Hybridization; Mice; Mice, Inbred C3H; Muscle Proteins; Precancerous Conditions; RNA, Long Noncoding; RNA, Untranslated; Urinary Bladder Neoplasms | 1998 |
Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound.
Topics: Alpha-Globulins; Animals; Butylhydroxybutylnitrosamine; Cacodylic Acid; Carcinogenicity Tests; DNA, Neoplasm; Herbicides; Hyperplasia; Immunohistochemistry; Kidney; Male; Precancerous Conditions; Rats; Rats, Inbred F344; Rats, Inbred Strains; Urinary Bladder; Urinary Bladder Neoplasms | 1998 |
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organ Specificity; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred F344; Sulfonamides; Urinary Bladder Neoplasms | 2000 |
Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Antioxidants; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Cell Cycle; Cyclin D1; Male; Mice; Mice, Inbred ICR; Papilloma; Precancerous Conditions; Silymarin; Urinary Bladder Neoplasms | 2002 |
Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats.
Topics: Animals; Autoradiography; Butylhydroxybutylnitrosamine; Carcinoma in Situ; Carcinoma, Papillary; Carcinoma, Transitional Cell; Cell Transformation, Neoplastic; DNA, Neoplasm; Female; Hyperplasia; Neoplasms, Experimental; Nitrosamines; Precancerous Conditions; Rats; Urinary Bladder Neoplasms | 1976 |
Morphology, classification and histogenesis of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced carcinomas in the urinary bladder of rats.
Topics: Adenocarcinoma; Animals; Butylhydroxybutylnitrosamine; Carcinoma; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Neoplasms, Experimental; Nitrosamines; Precancerous Conditions; Rats; Urinary Bladder Neoplasms | 1977 |
A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Female; Neoplasms, Experimental; Nitrosamines; Precancerous Conditions; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1979 |
Concanavalin A agglutination of bladder cells of rats treated with bladder carcinogens; a rapid new test to detect bladder carcinogens.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cell Aggregation; Concanavalin A; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Male; Neoplasms, Experimental; Precancerous Conditions; Rats; Urinary Bladder; Urinary Bladder Neoplasms | 1978 |
Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
Topics: 3,3'-Dichlorobenzidine; Animals; Benzidines; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Drug Synergism; Fatty Liver; Formamides; Liver; Male; Neoplasms, Experimental; Nitrosamines; Papilloma; Precancerous Conditions; Rats; Urinary Bladder; Urinary Bladder Neoplasms | 1977 |
Early changes caused by N-butyl-N-(4-hydroxybutyl)nitrosamine in the bladder epithelium of different animal species.
Topics: Animals; Butylhydroxybutylnitrosamine; Cricetinae; Guinea Pigs; Hyperplasia; Male; Mice; Microscopy, Electron; Neoplasms, Experimental; Precancerous Conditions; Rats; Species Specificity; Urinary Bladder Neoplasms | 1976 |
The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
Topics: Administration, Intravesical; Administration, Oral; Animals; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Dianhydrogalactitol; Doxorubicin; Female; Mitolactol; Papilloma; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Urinary Bladder Neoplasms | 1992 |
Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Ascorbic Acid; Body Weight; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Butylhydroxybutylnitrosamine; Carcinogens; Epithelium; Ethoxyquin; Male; Mucous Membrane; Organ Size; Papilloma; Precancerous Conditions; Rats; Rats, Inbred F344; Uracil; Urinary Bladder; Urinary Bladder Neoplasms | 1991 |
Nucleolar organizer regions in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Butylhydroxybutylnitrosamine; Hyperplasia; Male; Nitrosamines; Nucleolus Organizer Region; Precancerous Conditions; Rats; Rats, Inbred ACI; Urinary Bladder Neoplasms | 1990 |
Effects of intravesical instillation of antitumor chemotherapeutic and immunotherapeutic agents on bladder lesion development in rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Administration, Intravesical; Animals; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Bleomycin; Butylhydroxybutylnitrosamine; Cisplatin; Drug Evaluation, Preclinical; Drug Interactions; Epithelium; Female; Nitrosamines; Picibanil; Precancerous Conditions; Rats; Rats, Inbred F344; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1987 |
[Animal models of bladder cancer].
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemical Phenomena; Chemistry; Disease Models, Animal; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Precancerous Conditions; Rats; Urinary Bladder Neoplasms | 1988 |
Nonspecific esterase reaction in hyperplastic urinary bladder epithelium induced by administration of N-butyl-N-(4-hydroxybutyl)nitrosamine, freezing and formalin instillation in rats.
Topics: Animals; Biomarkers, Tumor; Butylhydroxybutylnitrosamine; Carboxylesterase; Carboxylic Ester Hydrolases; Epithelium; Formaldehyde; Freezing; Hyperplasia; Male; Precancerous Conditions; Rats; Rats, Inbred Strains; Urinary Bladder; Urinary Bladder Neoplasms | 1988 |
Lipid composition of the plasma membrane isolated from normal and precancerous rat bladder epithelium.
Topics: Animals; Butylhydroxybutylnitrosamine; Cell Membrane; Epithelium; Fatty Acids; Male; Membrane Lipids; Microscopy, Electron; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Precancerous Conditions; Rats; Rats, Inbred Strains; Urinary Bladder; Urinary Bladder Neoplasms | 1987 |
Reduction in responsiveness of thymocytes to phytohemagglutinin during bladder tumor induction and restorative effects of thymosin fraction 5 in rats.
Topics: Animals; Butylhydroxybutylnitrosamine; Female; Lymphocyte Activation; Phytohemagglutinins; Precancerous Conditions; Rats; Rats, Inbred Strains; T-Lymphocytes; Thymosin; Thymus Gland; Time Factors; Urinary Bladder Neoplasms | 1987 |
Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Acetates; Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Dose-Response Relationship, Drug; Kidney; Male; Nitrilotriacetic Acid; Organ Size; Papilloma; Precancerous Conditions; Rats; Rats, Inbred Strains; Urinary Bladder; Urinary Bladder Neoplasms | 1985 |
Promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in rats.
Topics: Acetates; Animals; Butylhydroxybutylnitrosamine; Carcinogens; Male; Nitrilotriacetic Acid; Papilloma; Precancerous Conditions; Rats; Rats, Inbred F344; Time Factors; Urinary Bladder Neoplasms | 1985 |
Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Ligation; Male; Papilloma; Precancerous Conditions; Rats; Rats, Inbred F344; Time Factors; Ureter; Urinary Bladder Neoplasms | 1985 |